acrolein has been researched along with Osteosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PN; Chu, SC; Hsieh, YS; Hsu, LS; Lai, YA; Lin, CY | 1 |
| Chen, J; Huang, H; Huang, Y; Luo, J; Luo, X; Tan, T; Wang, N; Wang, Y; Yang, C; Yang, S; Zhang, L | 1 |
| Lelieveld, P; van Putten, LM | 1 |
3 other study(ies) available for acrolein and Osteosarcoma
| Article | Year |
|---|---|
Cinnamaldehyde decreases the invasion and u-PA expression of osteosarcoma by down-regulating the FAK signalling pathway.
Topics: Acrolein; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Osteosarcoma; Signal Transduction; Urokinase-Type Plasminogen Activator | 2022 |
Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Bone Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
Topics: Acrolein; Animals; Antineoplastic Agents; Biotransformation; Cells, Cultured; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Hydroxylation; Ifosfamide; Leukemia L1210; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasms, Experimental; Nitrogen Mustard Compounds; Osteosarcoma; Oxazines | 1976 |